icon-folder.gif   Conference Reports for NATAP  
 
  62th Annual Meeting of the American Association for the Study of Liver Diseases San Francisco 2011 Nov 6-9 Back grey_arrow_rt.gif
 
 
 
Discovery of MK-4882, a Novel Inhibitor of HCV NS5a with an Attractive Pre-clinical Profile
 
 
  Reported by Jules Levin AASLD Nov 6-9 2011 San Francisco, CA
 
Steven W. Ludmerer, Christine Fandozzi, Qian Huang, Stacia Kargman, Rong Liu, Peter Meinke, David B. Olsen, and Craig A. Coburn Merck Research Laboratories, Whitehouse Station, NJ

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif